BlackRock
DBTX

BlackRock’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

BlackRock’s Portfolio DBTX Stock Details DBTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,811,483
Closed -$6.97M – 5566
2023
Q2 		$6.97M Buy
1,811,483
+5,337
+0.3% +$19.6K ﹤0.01% 3577
2023
Q1 		$5.45M Buy
1,806,146
+1,038
+0.1% +$3.59K ﹤0.01% 3592
2022
Q4 		$3.7M Sell
1,805,108
-81,732
-4% -$249K ﹤0.01% 3868
2022
Q3 		$6.53M Sell
1,886,840
-7,641
-0.4% -$34.8K ﹤0.01% 3633
2022
Q2 		$7.98M Sell
1,894,481
-2,742
-0.1% -$6.48K ﹤0.01% 3616
2022
Q1 		$5.77M Buy
1,897,223
+801,010
+73% +$3.07M ﹤0.01% 3881
2021
Q4 		$5.1M Sell
1,096,213
-725,337
-40% -$4.99M ﹤0.01% 3988
2021
Q3 		$14M Sell
1,821,550
-2,760
-0.2% -$21.1K ﹤0.01% 3509
2021
Q2 		$15.7M Sell
1,824,310
-332,494
-15% -$2.93M ﹤0.01% 3439
2021
Q1 		$24.5M Buy
+2,156,804
New +$33.8M ﹤0.01% 3075

Other funds holding DBTX

ACA
Atlas Capital Advisors Jackson, Wyoming $914M AUM

BlackRock's DBTX Position: Q3 2023 in Review

BlackRock sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 1,811,483 shares — an estimated $6.97M sold.

BlackRock first reported a position in DBTX in Q1 2021 and held it in 10 quarters. The position peaked at $24.5M in Q1 2021. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

  • BlackRock reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • BlackRock sold 1,811,483 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $6.97M.
  • BlackRock first reported a position in Decibel Therapeutics, Inc. Common Stock in Q1 2021 and held it in 10 quarters.
  • BlackRock's Decibel Therapeutics, Inc. Common Stock position peaked at $24.5M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.